A 6-year-old girl from rural India presents with a 2-month history of low-grade fever, weight loss, and a persistent cough. Chest X-ray shows a right upper lobe infiltrate with hilar lymphadenopathy but no cavitation. Sputum smear microscopy is negative. Which finding best distinguishes drug-susceptible TB from drug-resistant TB at this stage of diagnosis?

Explanation

## Distinguishing Drug-Susceptible from Drug-Resistant TB in Children ### Clinical Context **Key Point:** At the time of initial diagnosis, drug susceptibility status cannot be reliably predicted by clinical or radiological features alone. The most important clinical discriminator is the **epidemiological history**: prior TB treatment or known contact with a drug-resistant TB (DR-TB) patient. **High-Yield:** In India, the prevalence of multidrug-resistant TB (MDR-TB) is significant. Risk stratification based on treatment history and contact exposure is the standard approach to guide empirical therapy decisions while awaiting drug susceptibility testing (DST) results. ### Why History Is the Best Discriminator | Risk Factor | Implication | | --- | --- | | **Prior TB treatment** | High risk of acquired drug resistance (especially if incomplete/irregular treatment) | | **Contact with known DR-TB patient** | High risk of primary drug resistance | | **No prior TB history, no DR-TB contact** | Presumed drug-susceptible; standard first-line therapy | | **Unknown contact history** | Requires careful assessment; may need expanded regimen | ### Clinical Pearl **Clinical Pearl:** The WHO and Indian TB guidelines recommend risk stratification at diagnosis. Children with a history of prior TB treatment or exposure to a DR-TB contact should be started on a drug-resistant TB regimen (e.g., containing fluoroquinolone + injectable agent) while awaiting DST confirmation. This is a critical decision point that cannot be made from imaging or smear status alone. ### Why Imaging Features Are Not Discriminatory **Warning:** Cavitation, lymph node size, and infiltrate pattern do NOT reliably distinguish drug-susceptible from drug-resistant TB. Both forms can present with identical radiological appearances. The absence of cavitation in this case reflects the child's age and immune status, not drug susceptibility. ### Why Smear Status Is Not Discriminatory Negative sputum smear microscopy is common in children (who typically have paucibacillary disease) and does not indicate drug susceptibility. Both drug-susceptible and drug-resistant TB can present with negative smears in pediatric patients. ### Why Lymphadenopathy Is Not Discriminatory Hilar and mediastinal lymphadenopathy is the hallmark of primary TB in children and occurs in both drug-susceptible and drug-resistant disease. It is not a discriminating feature. ### Mnemonic for Risk Stratification **Mnemonic:** **PRIOR** — Prior treatment, Resistant contact, Immunocompromised status, Outbreak exposure, Recurrent disease - Any of these factors warrants consideration of DR-TB regimen pending DST.